Nightshade Vegetables Aren ’ t Actually Bad for You
If you’ve ever gone down the rabbit hole of health and wellness trends online, you’ve likely stumbled upon the so-called shadowy side of nightshades—vegetables that include tomatoes, potatoes, eggplants, and peppers. What’s made them suddenly newsworthy is that they’ve been singled out by self-proclaimed wellness experts and celebrity dieters as culprits behind a range of health issues, from arthritis to autoimmune disease flare-ups and indigestion. While there’s little scientific evidence for these claims, some people report feeling better after cutting nightshades from their diets. ...
Source: TIME: Health - March 26, 2024 Category: Consumer Health News Authors: Claire Sibonney Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

Mouse Study Yields Clues to Why Psoriasis Worsens
MONDAY, March 25, 2024 -- Australian researchers say they have identified a gene mutation that causes the skin disease psoriasis. A chronic inflammatory condition, psoriasis causes red, scaly, itchy patches on the skin. Some patients also develop... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 25, 2024 Category: General Medicine Source Type: news

Picture quiz: Psoriasis
The Nursing in Practice ‘picture quizzes’ aim to test your knowledge through photo presentations of symptoms. Work your way through them to understand the key clinical problems faced by patients, and how to correctly identify them. Press ‘start’ below to begin the quiz.  A 25-year-old male patient presents with these red, scaly bumps on his... Read moreThe post Picture quiz: Psoriasis appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - March 20, 2024 Category: Nursing Authors: Mollie Fraser-Andrews Tags: Dermatology Quiz toenail Source Type: news

FDA Expands Approval of Treatment for GPP FDA Expands Approval of Treatment for GPP
Spesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news

FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo
Ingelheim, Germany, March 19, 2024 -- Boehringer Ingelheim today announced that the US Food and Drug Administration (FDA) has approved Spevigo (spesolimab-sbzo) injection for the treatment of generalized pustular psoriasis (GPP) in adults and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 19, 2024 Category: Drugs & Pharmacology Source Type: news

AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis
FRIDAY, March 15, 2024 -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 15, 2024 Category: Pharmaceuticals Source Type: news

Short-Term High-Dose Psoriasis Therapy Shows Potential for Long-Term Disease Control
(MedPage Today) -- SAN DIEGO -- Short-term, high-dose treatment with risankizumab (Skyrizi) induced long-term control of plaque psoriasis in association with eradication of resident memory T cells (TRM), a small proof-of-principle study showed... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 13, 2024 Category: Dermatology Source Type: news

Investors put skin in Peninsula biotech's psoriasis game, and it delivers results
Alumis is now armed with a half-billion in cash and a wide range of targets, starting with psoriasis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 12, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Home-Based Phototherapy for Psoriasis Matches Office Efficacy With Better QOL
(MedPage Today) -- SAN DIEGO -- Home-based phototherapy for psoriasis achieved outcomes similar to office-based therapy, suggesting a potential for more convenient, less expensive treatment for some patients, according to a study reported here... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 11, 2024 Category: Dermatology Source Type: news

Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control
Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 11, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Home- and Office-Based Phototherapy for Psoriasis Compared Home- and Office-Based Phototherapy for Psoriasis Compared
The multicenter LITE trial included 783 patients at 42 sites in the United States.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 10, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news

Psoriasis Study Shows a Path for Considering US Drug Costs Psoriasis Study Shows a Path for Considering US Drug Costs
Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis
TUESDAY, March 5, 2024 -- For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2024 Category: Pharmaceuticals Source Type: news

New Data on First-Line Psoriasis Drug'Very Reassuring'New Data on First-Line Psoriasis Drug'Very Reassuring '
A higher cumulative dose of methotrexate taken did not increase the risk for liver fibrosis, but excess weight, metabolic syndrome, and diabetes did.Medscape News UK (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 1, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Generic SpA Screening Tool Needed Across Comorbid Diseases Generic SpA Screening Tool Needed Across Comorbid Diseases
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients with uveitis or IBD, compared with psoriasis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 1, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news